Insider Transactions Reported by 19 Insiders of Caribou Biosciences, Inc.

Symbol
CRBU on Nasdaq
Location
Berkeley, CA

Insiders trading volume in the past year

Caribou Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
FMR LLC Other* $9,836,921 27 Jul 2021
Rachel E. Haurwitz President and CEO, Director $3,738,142 +$20,400 +0.55% 14 Mar 2025
BARBARA G. MCCLUNG Chief Legal Officer $951,118 -$4,811 -0.5% 20 Feb 2025
Steven Kanner Chief Scientific Officer $640,767 -$4,811 -0.75% 20 Feb 2025
Syed Ali-aamir Rizvi Chief Medical Officer $528,134 21 Feb 2023
Jason O'Byrne Chief Financial Officer $511,703 20 Feb 2024
Ruhi Ahmad Khan Chief Business Officer $442,754 -$4,811 -1.1% 20 Feb 2025
Ryan Fischesser VP of Finance and Controller $319,717 20 Nov 2024
DAVID LEE JOHNSON Director $106,255 20 Feb 2025
Scott Braunstein Director $106,255 20 Feb 2025
Dara Richardson-Heron Director $106,255 20 Feb 2025
Natalie Sacks Director $106,255 20 Feb 2025
ANDREW GUGGENHIME Director $106,255 20 Feb 2025
Ran Zheng Director $57,835 20 Feb 2025
Nancy Whiting Director $57,835 20 Feb 2025
Timothy P. Kelly Chief Technology Officer $50,625 20 Feb 2025
Sriram Ryali Chief Financial Officer $24,651 +$24,651 29 Jan 2025
Tina M. Albertson Chief Medical Officer $19,695 20 Feb 2025
Jeffrey Long-McGie Director 22 Jul 2021

Recent Insider Transactions by Companies or Individuals for Caribou Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.